MedPath

Evaluation of the effect of Oak powder for the treatment of leishmaniasis.

Not Applicable
Recruiting
Conditions
eishmaniasis.
Leishmaniasis
Registration Number
IRCT20201226049841N1
Lead Sponsor
Marham Sazan Moghan Daroo Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with active leishmaniasis ulcers on a part of their body.
Patients with less than 4 months of leishmaniasis develops on their skin.

Exclusion Criteria

Patients with inactive leishmaniasis on their skin.
Any drug allergy recognition by medical practitioner.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Wounds larger than = 3 cm. Timepoint: Before treatments begin and 8 weeks after it. Method of measurement: Direct blood smear and PCR test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath